CREDIT SUISSE AG/ - BLUEBIRD BIO INC ownership

BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 178 filers reported holding BLUEBIRD BIO INC in Q1 2023. The put-call ratio across all filers is 0.92 and the average weighting 0.0%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of BLUEBIRD BIO INC
ValueSharesWeighting
Q3 2023$5,425,428
-10.9%
1,784,680
-3.6%
0.01%0.0%
Q2 2023$6,092,448
+13.5%
1,851,808
+9.7%
0.01%
+20.0%
Q1 2023$5,368,553
-53.1%
1,688,224
+2.0%
0.01%
-58.3%
Q4 2022$11,456,288
+14.0%
1,655,533
+4.3%
0.01%
+9.1%
Q3 2022$10,048,000
+51.4%
1,587,345
-1.0%
0.01%
+57.1%
Q2 2022$6,638,000
-37.9%
1,603,353
-27.3%
0.01%
-22.2%
Q1 2022$10,693,000
-51.3%
2,204,763
+0.2%
0.01%
-25.0%
Q4 2021$21,972,000
-42.6%
2,199,297
+9.7%
0.01%
-42.9%
Q3 2021$38,302,000
-55.8%
2,004,292
-26.0%
0.02%
-54.3%
Q2 2021$86,623,000
+21.4%
2,708,641
+14.5%
0.05%
+24.3%
Q1 2021$71,327,000
-8.5%
2,365,740
+31.3%
0.04%
-2.6%
Q4 2020$77,966,000
+58.2%
1,801,876
+97.3%
0.04%
+22.6%
Q3 2020$49,268,000
+15.8%
913,206
+31.0%
0.03%0.0%
Q2 2020$42,550,000
+88.2%
697,061
+41.7%
0.03%
+55.0%
Q1 2020$22,614,000
-34.2%
492,047
+25.7%
0.02%
-20.0%
Q4 2019$34,352,000
-57.3%
391,458
-55.3%
0.02%
-63.2%
Q3 2019$80,437,000
+80.1%
876,024
+149.6%
0.07%
+70.0%
Q2 2019$44,651,000
-9.8%
351,033
+11.5%
0.04%
-11.1%
Q1 2019$49,525,000
+35.9%
314,784
-14.3%
0.04%
+18.4%
Q4 2018$36,430,000
-3.9%
367,232
+41.4%
0.04%
+11.8%
Q3 2018$37,921,000
+17.7%
259,738
+26.6%
0.03%
+6.2%
Q2 2018$32,213,000
-28.8%
205,240
-22.6%
0.03%
-23.8%
Q1 2018$45,264,000
+60.0%
265,088
+66.9%
0.04%
+68.0%
Q4 2017$28,283,000
+95.5%
158,806
+50.8%
0.02%
+78.6%
Q3 2017$14,468,000
+52.7%
105,331
+16.8%
0.01%
+55.6%
Q2 2017$9,477,000
-18.3%
90,204
-29.3%
0.01%
-10.0%
Q1 2017$11,596,000
+80.5%
127,563
+22.5%
0.01%
+66.7%
Q4 2016$6,423,000
-6.5%
104,096
+2.7%
0.01%
-14.3%
Q3 2016$6,869,000
+71.3%
101,322
+9.3%
0.01%
+75.0%
Q2 2016$4,011,000
-11.0%
92,666
-12.6%
0.00%
-20.0%
Q1 2016$4,507,000
-2.4%
106,043
+47.5%
0.01%0.0%
Q4 2015$4,616,000
-21.2%
71,883
+5.0%
0.01%
-28.6%
Q3 2015$5,856,000
-77.8%
68,440
-56.3%
0.01%
-73.1%
Q2 2015$26,376,000
+174.2%
156,661
+96.7%
0.03%
+160.0%
Q1 2015$9,619,000
+15.7%
79,659
-12.2%
0.01%
+42.9%
Q4 2014$8,316,000
+181.7%
90,680
+10.2%
0.01%
+250.0%
Q3 2014$2,952,000
+47.2%
82,277
+58.2%
0.00%0.0%
Q2 2014$2,006,000
+53.2%
51,996
-9.6%
0.00%
+100.0%
Q1 2014$1,309,00057,5390.00%
Other shareholders
BLUEBIRD BIO INC shareholders Q1 2023
NameSharesValueWeighting ↓
Monashee Investment Management LLC 125,000$13,131,0005.55%
Cormorant Asset Management, LP 275,000$28,889,0004.79%
Eventide Asset Management 569,700$59,847,0003.73%
Crosspoint Capital Strategies, LLC 28,937$3,040,0002.66%
Casdin Capital, LLC 65,000$6,828,0002.53%
ARK Investment Management 119,683$12,573,0002.45%
RTW INVESTMENTS, LP 104,383$10,965,0002.31%
Taylor Wealth Management Partners 38,368$4,031,0001.82%
First Light Asset Management, LLC 33,780$3,549,0001.19%
Atika Capital Management LLC 25,000$2,627,0000.92%
View complete list of BLUEBIRD BIO INC shareholders